Horizon Pharma Buys Crealta Holdings for $510M
Horizon Pharma said today it has agreed to acquire Crealta Holdings for $510 million in cash, in a deal that expands and broadens the buyer’s orphan drug business. The deal reflects Horizon Pharma’s long-range…
Read guide →